NCT05935995

Brief Summary

Study to evaluate the use of confocal microscopy for detecting resection margins in patients undergoing surgery for basal cell carcinoma of skin and squamous Cell Carcinoma of Head and Neck

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 7, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

November 28, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

1.6 years

First QC Date

June 27, 2023

Last Update Submit

November 21, 2025

Conditions

Keywords

margin surgicalconfocal microscopyconventional histopathology (H&E)

Outcome Measures

Primary Outcomes (1)

  • Sensitivity and Specificity of Confocal Microscopy Diagnosis Compared to Gold Standard

    The concordance of intraoperative diagnosis between the two methods will be assessed by the condition of the margins of surgical specimens. Diagnostic accuracy will be measured by the sensitivity and specificity of confocal microscopy, using conventional histology reports from extemporaneous examination as the gold standard. * negative margins (absence of tumour cells) ; * positive margins (presence of tumour cells).

    1 day

Study Arms (1)

Microscopy confocal

EXPERIMENTAL
Other: microscopy confocal (Histolog Scanner)

Interventions

Surgical margins of tumor samples will be examined by conventional histopathology (H\&E) and confocal microscopy (Histolog® scanner, SamanTree Medical, Switzerland). Depending on the histopathological result obtained between the two methods, the patient may benefit directly from early surgery if the experimental result confirms the presence of positive margins (excluding the learning curve). A learning curve will be established over the first fifteen surgeries, enabling surgical teams to gain experience and systematize specimen flattening. This learning curve will also enable reference images to be produced. The procedure will be carried out by the surgeon and the pathologist in the operating room during this phase.

Microscopy confocal

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient ≥18 years old
  • Squamous cell or basal cell tumor (1 to 4 cm) of mucous or cutaneous origin.
  • Patient whose surgical indication has been validated in a consultation meeting
  • Patients with scheduled surgery
  • WHO\< or =2
  • ASA \< 3
  • Patient affiliated to the social security system
  • Patient has understood, signed and dated the consent form.

You may not qualify if:

  • History of irradiation in the surgical area
  • Women who are pregnant or who are breast-feeding.
  • Persons deprived of their liberty or under guardianship (including curators)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut de Cancerologie de Lorraine

Vandœuvre-lès-Nancy, 54500, France

Location

MeSH Terms

Conditions

Squamous Cell Carcinoma of Head and NeckCarcinoma, Basal CellMargins of Excision

Interventions

Microscopy, Confocal

Condition Hierarchy (Ancestors)

Carcinoma, Squamous CellCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasms, Basal CellMorphological and Microscopic FindingsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MicroscopyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • GILLES DOLIVET, MD

    Institut de Cancérologie de Lorraine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2023

First Posted

July 7, 2023

Study Start

November 28, 2023

Primary Completion

June 21, 2025

Study Completion

March 1, 2026

Last Updated

November 28, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations